1. 40P Can we predict which TIL products will react against NSCLC tumours based on the immune infiltrates?. (December 2022) Authors: Castenmiller, S.; Kanagasabesan, N.; de Groot, R.; Guislain, A.; van Loenen, M.; Monkhorst, K.; Hartemink, K.; Klomp, H.M.; Smit, E.; Haanen, J.B.A.G.; Wolkers, M. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗